相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting Microglial Metabolic Rewiring Synergizes with Immune-Checkpoint Blockade Therapy for Glioblastoma
Zengpanpan Ye et al.
CANCER DISCOVERY (2023)
Macrophages and microglia in glioblastoma: heterogeneity, plasticity, and therapy
Fatima Khan et al.
JOURNAL OF CLINICAL INVESTIGATION (2023)
Nano-ultrasonic Contrast Agent for Chemoimmunotherapy of Breast Cancer by Immune Metabolism Reprogramming and Tumor Autophagy
Xupeng Yang et al.
ACS NANO (2022)
A Micro-Environment Regulator for Filling the Clinical Treatment Gap after a Glioblastoma Operation
Yiwen Zhang et al.
ADVANCED HEALTHCARE MATERIALS (2022)
Mature dendritic cell-derived dendrosomes swallow oxaliplatin-loaded nanoparticles to boost immunogenic chemotherapy and tumor antigen-specific immunotherapy
Xing Chen et al.
BIOACTIVE MATERIALS (2022)
Central nervous system immune interactome is a function of cancer lineage, tumor microenvironment, and STAT3 expression
Hinda Najem et al.
JCI INSIGHT (2022)
Engineered Macrophage-Membrane-Coated Nanoparticles with Enhanced PD-1 Expression Induce Immunomodulation for a Synergistic and Targeted Antiglioblastoma Activity
Tieying Yin et al.
NANO LETTERS (2022)
Interrogating glioma-M2 macrophage interactions identifies Gal-9/Tim-3 as a viable target against PTEN-null glioblastoma
Xiangrong Ni et al.
SCIENCE ADVANCES (2022)
Next Steps for Immunotherapy in Glioblastoma
Toni Q. Cao et al.
CANCERS (2022)
OMIP-079: Cell cycle of CD4+ and CD8+ naive/memory T cell subsets, and of Treg cells from mouse spleen
Ambra Natalini et al.
CYTOMETRY PART A (2021)
A dual-guide bioinspired drug delivery strategy of a macrophage-based carrier against postoperative triple-negative breast cancer recurrence
Yue Qiu et al.
JOURNAL OF CONTROLLED RELEASE (2021)
A Virus-Mimicking Nucleic Acid Nanogel Reprograms Microglia and Macrophages for Glioblastoma Therapy
Xihui Gao et al.
ADVANCED MATERIALS (2021)
Immunostimulant hydrogel for the inhibition of malignant glioma relapse post-resection
Jing Zhang et al.
NATURE NANOTECHNOLOGY (2021)
Current status and recent advances in reirradiation of glioblastoma
Giuseppe Minniti et al.
RADIATION ONCOLOGY (2021)
Asynchronous blockade of PD-L1 and CD155 by polymeric nanoparticles inhibits triple-negative breast cancer progression and metastasis
Chuanrong Chen et al.
BIOMATERIALS (2021)
IL-10 in glioma
Samuel S. Widodo et al.
BRITISH JOURNAL OF CANCER (2021)
Macrophage-mediated multi-mode drug release system for photothermal combined with anti-inflammatory therapy against postoperative recurrence of triple negative breast cancer
Kebai Ren et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)
Phenotypic plasticity of myeloid cells in glioblastoma development, progression, and therapeutics
Zengpanpan Ye et al.
ONCOGENE (2021)
Tumor-associated hematopoietic stem and progenitor cells positively linked to glioblastoma progression
I-Na Lu et al.
NATURE COMMUNICATIONS (2021)
Debris-stimulated tumor growth: a Pandora's box?
Victoria M. Haak et al.
CANCER AND METASTASIS REVIEWS (2021)
Macrophage-Disguised Manganese Dioxide Nanoparticles for Neuroprotection by Reducing Oxidative Stress and Modulating Inflammatory Microenvironment in Acute Ischemic Stroke
Chao Li et al.
ADVANCED SCIENCE (2021)
Tunable phosphate-mediated stability of Ce3+ ions in cerium oxide nanoparticles for enhanced switching efficiency of their anti/pro-oxidant activities
Tamaki Naganuma
BIOMATERIALS SCIENCE (2021)
The blood-brain barrier: Physiology and strategies for drug delivery
Rucha Pandit et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
VEGF-C-driven lymphatic drainage enables immunosurveillance of brain tumours
Eric Song et al.
NATURE (2020)
Selective targeting of nanomedicine to inflamed cerebral vasculature to enhance the blood-brain barrier
Oscar A. Marcos-Contreras et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Immunotherapy for Malignant Glioma: Current Status and Future Directions
Hongxiang Wang et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2020)
Endocytosis of Extracellular Vesicles and Release of Their Cargo from Endosomes
Bhagyashree S. Joshi et al.
ACS NANO (2020)
Gasdermin E suppresses tumour growth by activating anti-tumour immunity
Zhibin Zhang et al.
NATURE (2020)
Cytokines and costimulation in acute graft-versus-host disease
Geoffrey R. Hill et al.
BLOOD (2020)
Management of glioblastoma: State of the art and future directions
Aaron C. Tan et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
The influx/efflux mechanisms of D-peptide ligand of nAChRs across the blood-brain barrier and its therapeutic value in treating glioma
Bing Han et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Tumour-intrinsic resistance to immune checkpoint blockade
Anusha Kalbasi et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Chemotherapy-generated cell debris stimulates colon carcinoma tumor growth via osteopontin
Jaimie Chang et al.
FASEB JOURNAL (2019)
Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma
Kurt A. Schalper et al.
NATURE MEDICINE (2019)
Modulation of temozolomide dose differentially affects T-cell response to immune checkpoint inhibition
Aida Karachi et al.
NEURO-ONCOLOGY (2019)
Triple combination immunotherapy with GVAX, anti-PD-1 monoclonal antibody, and agonist anti-OX40 monoclonal antibody is highly effective against murine intracranial glioma
Nusrat Jahan et al.
ONCOIMMUNOLOGY (2019)
The interplay between glioblastoma and microglia cells leads to endothelial cell monolayer dysfunction via the interleukin-6-induced JAK2/STAT3 pathway
Marina Couto et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy
Monica Pascual-Garcia et al.
NATURE COMMUNICATIONS (2019)
Transcytosis at the blood-brain barrier
Swathi Ayloo et al.
CURRENT OPINION IN NEUROBIOLOGY (2019)
Rationally designed peptide-conjugated gold/platinum nanosystem with active tumor-targeting for enhancing tumor photothermal-immunotherapy
Qian Yang et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Tumour cell-derived debris and IgG synergistically promote metastasis of pancreatic cancer by inducing inflammation via tumour-associated macrophages
Qi Chen et al.
BRITISH JOURNAL OF CANCER (2019)
Oleanolic acid attenuates cisplatin-induced nephrotoxicity in mice and chemosensitizes human cervical cancer cells to cisplatin cytotoxicity
Iva Potocnjak et al.
FOOD AND CHEMICAL TOXICOLOGY (2019)
The current state of immunotherapy for gliomas: an eye toward the future
Peter E. Fecci et al.
JOURNAL OF NEUROSURGERY (2019)
Nanomaterial-based blood-brain-barrier (BBB) crossing strategies
Jinbing Xie et al.
BIOMATERIALS (2019)
Emerging Nano-/Microapproaches for Cancer Immunotherapy
Yu Mi et al.
ADVANCED SCIENCE (2019)
被撤回的出版物: IL-6/STAT3 pathway intermediates M1/M2 macrophage polarization during the development of hepatocellular carcinoma (Retracted article. See vol. 123, pg. 1118, 2022)
Zi Yin et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Carrier-Free, Pure Nanodrug Formed by the Self-Assembly of an Anticancer Drug for Cancer Immune Therapy
Lulu Fan et al.
MOLECULAR PHARMACEUTICS (2018)
Binary Cooperative Prodrug Nanoparticles Improve Immunotherapy by Synergistically Modulating Immune Tumor Microenvironment
Bing Feng et al.
ADVANCED MATERIALS (2018)
TLR2 Promotes Glioma Immune Evasion by Downregulating MHC Class II Molecules in Microglia
Jiawen Qian et al.
CANCER IMMUNOLOGY RESEARCH (2018)
The roles of microglia macrophages in tumor progression of brain cancer and metastatic disease
Shih-Ying Wu
Frontiers in Bioscience-Landmark (2017)
Microglia in steady state
Katrin Kierdorf et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Blocking the PD-1/PD-L1 pathway in glioma: a potential new treatment strategy
Song Xue et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Vaccine-based immunotherapeutic approaches to gliomas and beyond
Michael Weller et al.
NATURE REVIEWS NEUROLOGY (2017)
CD69: from activation marker to metabolic gatekeeper
Danay Cibrian et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2017)
Investigation of endosome and lysosome biology by ultra pH-sensitive nanoprobes
Chensu Wang et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Nanoparticles Coated with Neutrophil Membranes Can Effectively Treat Cancer Metastasis
Ting Kang et al.
ACS NANO (2017)
Immunogenic cell death in cancer and infectious disease
Lorenzo Galluzzi et al.
NATURE REVIEWS IMMUNOLOGY (2017)
A therapeutic cancer vaccine against GL261 murine glioma
Mark S. Kindy et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study
Brigitta G. Baumert et al.
LANCET ONCOLOGY (2016)
Safety and activity of nivolumab (nivo) monotherapy and nivo in combination with ipilimumab (ipi) in recurrent glioblastoma (GBM): Updated results from checkmate-143.
David A. Reardon et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Blocking of the PD-1/PD-L1 Interaction by a D-Peptide Antagonist for Cancer Immunotherapy
Hao-Nan Chang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)
Redirection of CD4+and CD8+T lymphocytes via an anti-CD3 x anti-CD19 bi-specific antibody combined with cytosine arabinoside and the efficient lysis of patient-derived B-ALL cells
Dongmei Fan et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2015)
Tumor Acidity-Sensitive Polymeric Vector for Active Targeted siRNA Delivery
Chun-Yang Sun et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
Structural and functional features of central nervous system lymphatic vessels
Antoine Louveau et al.
NATURE (2015)
Effector lymphocyte-induced lymph node-like vasculature enables naive T-cell entry into tumours and enhanced anti-tumour immunity
J. David Peske et al.
NATURE COMMUNICATIONS (2015)
Modulation of cerebral endothelial cell function by TGF-β in glioblastoma: VEGF-dependent angiogenesis versus endothelial mesenchymal transition
Shanmugarajan Krishnan et al.
ONCOTARGET (2015)
Resident microglia, and not peripheral macrophages, are the main source of brain tumor mononuclear cells
Annett Mueller et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Perforin and granzymes: function, dysfunction and human pathology
Ilia Voskoboinik et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
Nicolas Bertrand et al.
ADVANCED DRUG DELIVERY REVIEWS (2014)
Immunotherapy for Brain Cancer: Recent Progress and Future Promise
Christopher M. Jackson et al.
CLINICAL CANCER RESEARCH (2014)
In vivo and ex vivo assessment of the blood brain barrier integrity in different glioblastoma animal models
Cindy Leten et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
A Phase 1 Trial of Oncolytic HSV-1, G207, Given in Combination With Radiation for Recurrent GBM Demonstrates Safety and Radiographic Responses
James M. Markert et al.
MOLECULAR THERAPY (2014)
Therapeutic activation of macrophages and microglia to suppress brain tumor-initiating cells
Susobhan Sarkar et al.
NATURE NEUROSCIENCE (2014)
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
Mark R. Gilbert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Fractionated radiotherapy is the main stimulus for the induction of cell death and of Hsp70 release of p53 mutated glioblastoma cell lines
Yvonne Rubner et al.
RADIATION ONCOLOGY (2014)
IFNα converts IL-22 into a cytokine efficiently activating STAT1 and its downstream targets
Malte Bachmann et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Interleukins in glioblastoma pathophysiology: implications for therapy
Y. T. Yeung et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Nanooncology: The Future of Cancer Diagnosis and Therapy
Avnesh S. Thakor et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
Glioblastoma and Other Malignant Gliomas A Clinical Review
Antonio Omuro et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
The role of Stat3 in glioblastoma multiforme
Rodney B. Luwor et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2013)
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
Stephanie M. Pyonteck et al.
NATURE MEDICINE (2013)
Current status of local therapy in malignant gliomas - A clinical review of three selected approaches
Tareq A. Juratli et al.
PHARMACOLOGY & THERAPEUTICS (2013)
Impact of Temozolomide on Immune Response during Malignant Glioma Chemotherapy
Sadhak Sengupta et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)
Differential macrophage programming in the tumor microenvironment
Brian Ruffell et al.
TRENDS IN IMMUNOLOGY (2012)
Synthetic Oleanane Triterpenoids: Multifunctional Drugs with a Broad Range of Applications for Prevention and Treatment of Chronic Disease
Karen T. Liby et al.
PHARMACOLOGICAL REVIEWS (2012)
Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC/D3 cell line
Eleni Markoutsa et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2011)
Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform
Che-Ming J. Hu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Microglial cell origin and phenotypes in health and disease
Kaoru Saijo et al.
NATURE REVIEWS IMMUNOLOGY (2011)
The Cell-Specific Induction of CXC Chemokine Ligand 9 Mediated by IFN-γ in Microglia of the Central Nervous System Is Determined by the Myeloid Transcription Factor PU.1
Sally L. Ellis et al.
JOURNAL OF IMMUNOLOGY (2010)
Experience with irinotecan for the treatment of malignant glioma
James J. Vredenburgh et al.
NEURO-ONCOLOGY (2009)
The effects of natalizumab on the innate and adaptive immune system in the central nervous system
Olaf Stueve
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
Modulation of dendritic cell differentiation by HLA-G and ILT4 requires the IL-6-STAT3 signaling pathway
Siyuan Liang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
CXCR4 antagonism increases T cell trafficking in the central nervous system and improves survival from West Nile virus encephalitis
Erin E. McCandless et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Induction of the genes for Cxcl9 and Cxcl10 is dependent on IFN-γ but shows differential cellular expression in experimental autoimmune encephalomyelitis and by astrocytes and microglia in vitro
Sally L. Carter et al.
GLIA (2007)
A novel small molecule inhibitor of signal transducers and activators of transcription 3 reverses immune tolerance in malignant glioma patients
S. Farzana Hussain et al.
CANCER RESEARCH (2007)
Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity
M Kortylewski et al.
NATURE MEDICINE (2005)
Impaired capacity for upregulation of MHC class II in tumor-associated microglia
JM Schartner et al.
GLIA (2005)
IL-6 is required for glioma development in a mouse model
J Weissenberger et al.
ONCOGENE (2004)
Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs
JK Olson et al.
JOURNAL OF IMMUNOLOGY (2004)
分享论文
